Publications by authors named "Emanuel Zerabruck"

Background And Study Aim: Endoscopic negative pressure therapy (ENPT) is well established in the treatment of perforations of various etiologies in the upper and lower gastrointestinal tract. For duodenal perforations exist only case reports and series. Different indications are possible for ENPT in duodenal position: primary therapy for leaks, preemptive therapy after surgery for example, after ulcer suturing or resection with anastomoses, or as second line therapy in cases of recurrent anastomotic insufficiencies with leakage of duodenal secretion.

View Article and Find Full Text PDF

Endoscopic negative pressure therapy is an effective treatment strategy for various defects of the gastrointestinal tract. The functional principle is based on an open-pore element, which is placed around a perforated drainage tube and connected to a vacuum source. The resulting open-pore suction device can undergo endoluminal or intracavitary placement.

View Article and Find Full Text PDF
Article Synopsis
  • - The text discusses the use of endoscopic negative pressure therapy as a treatment for gastrointestinal leaks, particularly focusing on its application for rare and dangerous duodenal diverticular perforations.
  • - Two cases are presented where patients diagnosed with perforated duodenal diverticula were successfully treated with this therapy alone, showing effective results despite initial inconclusive symptoms.
  • - The authors emphasize the potential of endoscopic negative pressure therapy as an alternative to surgical intervention for duodenal diverticular perforations, suggesting it should be considered as the first line of treatment.
View Article and Find Full Text PDF

Background: Indications for endoscopic retrograde cholangiopancreatography (ERCP) in children differ from adults. Paucity of data and concerns about potential lower effectiveness and more side effects limit its use even in high volume centers. We retrospectively analyzed indications, success rates, limitations, and side effects of ERCPs in children <18 years.

View Article and Find Full Text PDF